Secukinumab's Pooled and Long-Term Safety: Analysis of 19 Psoriasis Clinical Trials Up to 5 Years of Treatment

Main Article Content

PCM van de Kerkhof
K Reich
CL Leonardi
A Blauvelt
NN Mehta
TF Tsai
R You
P Papanastasiou
M Milutinovic
CEM Griffiths

Keywords

psoriasis, secukinumab, clinical trial

Abstract

Abstract not available.

 

Disclosures: Study sponsored by Novartis.

 

Copyright 2018 SKIN

Most read articles by the same author(s)

<< < 1 2 3